|
|
|
|
|
|
|
|
|
John Bumpus, EVP,
Administration
|
|
Mike Coggin, EVP,
CFO
|
|
Victor Giovanetti, EVP, Hospital Operations
|
|
Rob Jay, EVP, Integrated Operations
|
|
Jennifer Peters, EVP, General Counsel
|
Human Resources
Communications
Marketing
Aviation
|
|
Audit Services
Ops Finance
Supply Chain
Reimbursement
Tax
Accounting
Risk Management
Treasury
Capital/ Construction
|
|
Hospitals
Quality and Clinical Operations
|
|
Transformation/ Integration Office
Ambulatory
(post-acute)
Physician Services
Growth and Outreach
Service Line Development
HITS
Revenue Cycle Management
Managed Care and Payor Transformation
|
|
Legal
Real Estate
|
As you will see, there will be some changes in how certain departments report through the organization. While we have decided
at an organizational level that this is the right structure for our business, there are still many questions to be addressed within each of these areas. I ask for your patience as our new executive team meets with department leaders and dives into
each of their respective areas to learn more and develop their vision for the future. As soon as we have more information, we will share it with you.
Finally, as I indicated in my last message to you, we are now at the point where we are working on integration planning in earnest, charging forward to
complete our merger in a timely manner and ensure as smooth a transition as possible. With this, I wanted to share one of the most important outcomes that we are working toward, which is to create
one company
, with
one
culture,
that is recognized as
THE leader in delivering high quality, community-based healthcare
.
While we continue to proceed
through this time of change and transition, I cannot thank you enough for your commitment to our mission and for staying focused on supporting the communities we serve.
Sincerely,
David Dill
DAVID DILL
P
RESIDENT
& COO
LifePoint Health
Additional Information and
Where to Find It
This communication relates to the proposed merger transaction involving the Company. In connection with the proposed
merger, the Company has filed a proxy statement and other relevant documents with the Securities and Exchange Commission (the SEC) and first mailed the proxy statement to its stockholders on September 27, 2018. This communication is
not a substitute for the proxy statement or any other document that the Company has filed with the SEC or send to its stockholders in connection with the proposed merger. BEFORE MAKING ANY VOTING DECISION, STOCKHOLDERS OF THE COMPANY ARE URGED TO
READ ALL RELEVANT DOCUMENTS FILED WITH THE SEC, INCLUDING THE PROXY STATEMENT, WHEN THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT THE PROPOSED TRANSACTION. Investors and security holders will be able to obtain the proxy
statement and other documents filed by the Company with the SEC (when available) free of charge at the SECs website, http://www.sec.gov, and the Companys website, www.lifepointhealth.net.
Participants in the Solicitation
The
Company and its directors and executive officers may be deemed to be participants in the solicitation of proxies from the holders of the Companys common stock in respect of the proposed transaction. Information about the directors and
executive officers of the Company is set forth in the Companys Annual Report on
Form 10-K for
the year ended December 31, 2017, filed with the SEC on February 23, 2018, and proxy
statement for its 2018 annual meeting of stockholders, filed with the SEC on April 25, 2018. Additional information regarding potential participants in the proxy solicitation and a description of their direct and indirect interests, by security
holdings or otherwise, is contained in the proxy statement and other relevant documents filed by the Company with the SEC in respect of the proposed transaction